Evidence map›Paper›PMID 26352598›Full record

ArticlePloS one2015

Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?

Meriem Bennabi, Richard Delorme, José Oliveira, Catherine Fortier, Mohamed Lajnef, Wahid Boukouaci, Jean-Paul Feugeas, François Marzais, Alexandru Gaman, Dominique Charron and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A ComprehensiveFrontiers in cellular and infection microbiology · 2018
    Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Meriem BennabiINSERM, U1160, Hôpital Saint Louis, Paris, France; INSERM, U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France.
Richard DelormeDHU Protect, Service de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Paris, France; Département de Génétique Humaine et Fonctions Cognitives, Institut Pasteur, Paris, France.
José OliveiraINSERM, U1160, Hôpital Saint Louis, Paris, France; INSERM, U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France.
Catherine FortierLaboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France.
Mohamed LajnefINSERM, U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France.
Wahid BoukouaciINSERM, U1160, Hôpital Saint Louis, Paris, France.
Jean-Paul FeugeasINSERM, U1137, Hôpital Bichat, Paris, France; Université Paris Diderot, Sorbonne Paris-Cité, Paris, France.
François MarzaisLaboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France.
Alexandru GamanINSERM, U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France.
Dominique CharronLaboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France; Université Paris Diderot, Sorbonne Paris-Cité, Paris, France.
Bijan GhalehCentre de Ressources Biologiques, Hôpitaux Universitaires Henri Mondor, Créteil, France.
Rajagopal KrishnamoorthyINSERM, U1160, Hôpital Saint Louis, Paris, France; Fondation FondaMental, Créteil, France.
Marion LeboyerINSERM, U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France; AP-HP, Pôle de Psychiatrie, DHU PePSY, Hôpitaux Universitaires Henri Mondor, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France.
Ryad TamouzaINSERM, U1160, Hôpital Saint Louis, Paris, France; Fondation FondaMental, Créteil, France; Laboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France; Université Paris Diderot, Sorbonne Paris-Cité, Paris, France.
Hôpital Saint-Louis · FRFondation FondaMental · FRHôpitaux Universitaires Henri-Mondor · FRHôpital Bichat-Claude-Bernard · FRHôpital Robert-Debré · FRInserm · FRSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn autism spectrum disorders (ASD), complex gene-environment interactions contribute to disease onset and progress. Given that gastro-intestinal dysfunctions are common in ASD, we postulated involvement of microbial dysbiosis in ASD and investigated, under a case-control design, the influence of DNA polymorphisms in the CLEC7A gene that encodes a pivotal fungal sensor, Dectin-1. MATERIAL AND

methodsDNAs from 478 ASD patients and 351 healthy controls (HC) were analyzed for the CLEC7A rs16910631G/A and rs2078178 A/G single nucleotide polymorphisms (SNPs). Differences in the distribution of allele, genotype and haplotype by Chi-square testing and nonparametric analysis by Kruskal-Wallis/Mann-Whitney tests, where appropriate, were performed. The free statistical package R.2.13 software was used for the statistical analysis.

resultsWe found that the CLEC7A rs2078178 G allele and GG genotype were more prevalent in HC as compared to ASD but failed to reach statistical significance for the latter (pc = 0.01, 0.06 respectively). However, after phenotype-based stratification, the CLEC7A rs2078178 G allele and GG genotype were found to be significantly more frequent in the Asperger group as compared to other ASD subsets (pc = 0.02, 0.01), a finding reinforced by haplotype analysis (rs2078178/rs16910631 G-G/G-G) (pc = 0.002). Further, intellectual quotient (IQ)-based stratification of ASD patients revealed that IQ values increase linearly along the CLEC7A rs2078178 AA, AG and GG genotypes (p = 0.05) and in a recessive manner (GG vs. AA+AG p = 0.02), further confirmed by haplotype distribution (CLEC7A rs2078178-16910631; A-G/A-G, A-G/G-G and G-G/G-G, p = 0.02, G-G/G-G vs. others, p = 0.01).

conclusionOur data suggest that the genetic diversity of CLEC7A gene influences the ASD phenotype by behaving as a disease specifier and imply that the genetic control of innate immune response could determine the ASD phenotype.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAllelesAutism Spectrum DisorderChildChild, PreschoolDectin-1DysbiosisFemaleGenetic Association StudiesGenotypeHaplotypesHumansImmunity, InnateLectins, C-TypeCLEC7A protein, humanDectin-1Lectins, C-Type

Identifiers

PMID26352598
PMCPMC4564239
OpenAlexW2103600348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.